WallStreetZenWallStreetZen

NASDAQ: NLSP
Nls Pharmaceutics Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Nls Pharmaceutics earnings were -$6.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest NLSP earnings report on Jun 30, 2024 announced Q2 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, NLSP reported annual earnings of -$12.2M, with -26.2% growth.

NLSP earnings history

Current Revenue
$0.0
Current Earnings
-$6.6M
Current Profit Margin
0%

NLSP Return on Equity

Current Company
N/A
Current Industry
22.8%
Current Market
33.7%

NLSP undefined

Current Company
-380.8%
Current Industry
3.5%
NLSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NLSP announces earnings.

NLSP undefined

Current Company
97.52%
Current Industry
21.3%
NLSP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NLSP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NLSP-$6.35M-$6.60MN/A-$6.74
PTIX-$5.48M-$5.53MN/A-$1.13
ELAB-$5.50M-$6.25MN/A-$78.48
ENTO-$18.01M-$18.30MN/A-$5.33
PLRZ-$1.18M-$1.55MN/A-$0.50
View Top Biotech Stocks

Nls Pharmaceutics Earnings Reports & History FAQ

What were Nls Pharmaceutics's earnings last quarter?

Nls Pharmaceutics (NASDAQ: NLSP) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total NLSP earnings for the quarter were N/A. In the same quarter last year, Nls Pharmaceutics's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Nls Pharmaceutics stock.

Is Nls Pharmaceutics profitable or losing money?

As of the last Nls Pharmaceutics earnings report, Nls Pharmaceutics is currently losing money. Nls Pharmaceutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$6.60 million, a 57.36% decrease year over year.

What was NLSP's earnings growth in the past year?

As of Nls Pharmaceutics's earnings date in Q2 2025, Nls Pharmaceutics's earnings has grown year over year. NLSP earnings in the past year totalled -$6.60 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.